Latest / The MaineHealth Podcast / Curbside Consult: Vaccines with Michael Madaio, DO
Transcript
- 0:10From the MaineHealth ACO, this is Curbside Consult, a podcast that brings together
- 0:15specialists and primary care providers for informal clinical discussions. I'm Mike Clark.
- 0:21And I'm Heather Ward. Mike and I
- 0:23are practicing family physicians and participants in the MaineHealth ACO.
- 0:29As we record this episode, we are entering into the respiratory virus season.
- 0:35So today we are going to discuss everything we need to know about the latest
- 0:42vaccine recommendations and maybe hopefully get into a little bit of interesting
- 0:46up-and-coming vaccine information.
- 0:49Yes, and joining us to accomplish this is Dr. Mike Madaio, a preventive medicine
- 0:56physician with MaineHealth Infectious Disease in Brunswick.
- 0:59Dr. Madaio is board-certified in infectious disease and internal medicine with
- 1:03additional training in preventative medicine and public health.
- 1:07And Mike, thank you so much for joining us today.
- 1:11Yeah, thank you both. It's very good to be here today.
- 1:14Well, I was hoping that maybe we could start with just a little bit more information
- 1:19about you. Like what got you into being a physician and specifically infectious disease?
- 1:27Yeah, great question. Well, it relates a lot to vaccines, actually.
- 1:31And when I was an undergrad, I was a biochemistry major, and I took a course
- 1:36in infectious diseases.
- 1:37And I was fascinated by how small, small microscopic bacteria and viruses can
- 1:44make big people so incredibly sick. You know, things you can't see,
- 1:48you can't necessarily taste them, you can't smell them, they're not perceivable.
- 1:52And that's why they went for thousands of years in human civilization without being detected.
- 1:57And kind And even more fascinatingly, the very small molecules,
- 2:01small, small 5ml injections of vaccines can sometimes completely eradicate or
- 2:06prevent certain infections.
- 2:08So that was just all very fascinating to me. When I went through medical school,
- 2:12I thought about other specialties.
- 2:14I obviously did my residency in internal medicine. So I thought about being
- 2:18a primary care or hospitalist, but I always felt like I'd forever regret not
- 2:23doing infectious disease.
- 2:24And then when I went to fellowship, I decided to do additional training in preventive
- 2:28medicine because I have a particular
- 2:31interest in not just treating complex infections, but preventing.
- 2:36The start of an infection, but also preventing infections from getting worse or advancing.
- 2:40We sometimes call those like primary, secondary, or tertiary prevention.
- 2:45That's fantastic. I wonder if we should just dive right into respiratory season
- 2:53vaccine recommendations since here we are.
- 2:57Yeah, absolutely. So there's been a few changes in the respiratory viruses,
- 3:02vaccines in the last year.
- 3:04Nothing that I would say is totally groundbreaking, but things I would want
- 3:08physicians in Maine to be aware of.
- 3:10One, for influenza, they have reformulated the vaccine based on strains from
- 3:16the Southern Hemisphere, as they have done every year.
- 3:18There were concerns about whether or not that would be possible due to our withdrawal
- 3:22from the World Health Organization.
- 3:24But similar to last year, it did happen. So I anticipate by the end of this
- 3:28month, those should be available at most pharmacies and orderable for primary
- 3:33care clinics and whatnot.
- 3:35Another exciting influenza vaccine topic is FluMist, which is the nasal live attenuated vaccine.
- 3:42It's been around for a long time now, but it just recently was approved for
- 3:45self-administration or caregiver administration.
- 3:48It's really kind of exciting because it's the first vaccine then that people
- 3:51could give to themselves or a loved one, which is just going to open up access
- 3:55points for vaccination.
- 3:57A caregiver could bring this home to a bed-bound, home-bound patient,
- 4:01for example, or nurses could bring it into the home for administration.
- 4:04Another kind of exciting thing, flu block, which is a relatively new recombinant
- 4:09vaccine, so just a slightly different technology than the typical flu shots.
- 4:14It's now approved down to age 9 instead of 18. So that's just something for
- 4:18people who practice pediatrics or family medicine to be aware of.
- 4:21That's just another alternative vaccine.
- 4:24There's also a new recommendation from the ACIP that I think we should go over.
- 4:30It's controversial, I will say, but essentially the recommendation is that now
- 4:35no vaccines contain thimerosal, which is the kind of old-fashioned preservative in vaccines.
- 4:42That actually has been absent from the vast majority of vaccine supplies for
- 4:46the last several decades.
- 4:47So this is kind of more a pen and paper intervention than an actual practical
- 4:52thing. But it is notable that some formulations of flu vaccine still have thimerosal.
- 4:57And so we're going to have to look at our supplies and make sure we're not giving
- 5:01those up because that has been put off limits by the federal government.
- 5:05Another kind of update, RSV, another very common respiratory virus in the fall
- 5:10season. This is a single dose. It was previously for only adults over the age of 75.
- 5:16It has now been expanded for adults age 50 to 75 that are increased risk.
- 5:22And that's actually a pretty broad classification of people.
- 5:26That could be people with COPD, coronary disease, congestive heart failure,
- 5:29diabetes. It's honestly almost anyone over the age of 50 can qualify for the RSV vaccine.
- 5:37On the pediatric side of things, there's now a second long-acting monoclonal
- 5:41antibody that can be given to infants if they were born, if they're born during
- 5:46the respiratory virus season. That's called inflonsia.
- 5:49Older monoclonal is called baefortis. And then for COVID-19,
- 5:53Really, the only change, again, kind of a controversial change, is.
- 5:57It has been downgraded from the CDC from a universal vaccine for everyone aged
- 6:03six months and older to an individualized risk-based kind of shared decision-making approach.
- 6:09Now, notably, that's what the CDC and the ACIP recommends, but other organizations
- 6:15like the American Academy of Pediatrics, the Infectious Disease Society of America,
- 6:20so on and so forth, they still strongly recommend the COVID vaccine for everyone
- 6:24aged six months and older, similar to influenza.
- 6:29But there is a disconnect and some debate there.
- 6:32Although not a respiratory virus per se, the pneumococcal vaccines have had some changes.
- 6:39Essentially, the age for universal vaccination for pneumococcal disease is now 50 instead of 65.
- 6:47That's because we've been seeing
- 6:48more and more younger people developing invasive pneumococcal disease.
- 6:52There's also a new vaccine, the PCV20.
- 6:56The brand name is Capvaxiv, if you're curious.
- 6:59That was added along to the PCV20 or the Prevnar20 and the PCV15, which is VaxNuvance.
- 7:07The PCV21 and 20 are nice because they're a single-dose option,
- 7:12unlike in the past years where you'd have to kind of mix and match conjugate
- 7:16vaccines with the polysaccharide vaccines, and it became very complicated.
- 7:21These are one-and-done vaccines for people who qualify.
- 7:24If you use the PCV15, though, you do need to follow it up with a PPSV23.
- 7:28So, I usually recommend people use the Prevnar-21 or 20.
- 7:33And then, of course, people with certain risk factors for pneumonia ages 19
- 7:38to 49 can also get the pneumococcal vaccines.
- 7:42That didn't change from last year to this year.
- 7:45I just was curious about the flu mist. So with it being live attenuated,
- 7:51are we being cautious about who we're giving that to.
- 7:55Yep. Yeah, absolutely. With all live attenuated vaccines, there's going to be
- 8:00a very small risk of getting a vaccine-derived infection from the vaccine.
- 8:05It's almost never as significant as the actual infection because these are attenuated,
- 8:10pathogens, but it is possible.
- 8:12It's particularly plausible in people that are immunocompromised.
- 8:16So, as a general rule, anyone that is pregnant or immunocompromised,
- 8:20whether that be from a natural cause of immunodeficiency or a medication like
- 8:25people with rheumatic diseases,
- 8:27the general recommendation is to avoid any sort of live vaccine for those populations.
- 8:32So yes, that would be, that's a very good point.
- 8:35And then I had another question about the RSV vaccine. I don't know with you,
- 8:41but like for me, my patients are kind of, they, some are like, I'm going to go get that.
- 8:48And like, it's going to save their lives. It's really important to go get.
- 8:52And then others are kind of like, I don't know.
- 8:56And as a primary care doctor, like, how much am I supposed to be pushing or
- 9:01encouraging patients to get the RSV vaccine?
- 9:06Yeah, good question. Well, I would say for people over the age of 75,
- 9:11it's like a checklist for every single one of those patients.
- 9:15It should be a discussion every time they come in if they have not gotten it.
- 9:19It's a one-time vaccine.
- 9:20It's not a yearly vaccine like influenza or COVID.
- 9:24People between the ages of 50 and 74, that's going to be more of a risk-based decision.
- 9:31So you'd want to self-select patients and not make it a table item for every
- 9:34patient that you see in your practice.
- 9:36As far as how much to recommend it, I generally would recommend it pretty strongly
- 9:42because in addition to influenza and COVID, it is the most common viral cause
- 9:47of severe infection in the respiratory virus season.
- 9:50We frequently see people admitted with very severe disease due to RSV.
- 9:54This vaccine has been out for several years now and it's dramatically affected
- 9:58the number of hospitalizations due to RSV.
- 10:00So I generally would recommend it pretty strongly.
- 10:03People sometimes ask me, of these three vaccines influence RSV COVID,
- 10:07what's the ranking of them? What should I push the hardest? And honestly,
- 10:11it's impossible to answer, right?
- 10:12Because every year, the spread of these various viruses is different.
- 10:16COVID a few years ago when it very first hit the United States was awful,
- 10:19right? Influenza year to year can be also very, very bad.
- 10:23It's almost impossible to predict before the respiratory virus season begins
- 10:27which is going to be the predominant pathogen.
- 10:30So generally, I would say that people who are concerned for their health and
- 10:34want to prevent diseases should get all three. Well, thank you for that.
- 10:38That helps me be able to...
- 10:41Go at it with a little bit more gusto. Yeah, yeah, me too.
- 10:46We're definitely encountering vaccine fatigue probably everywhere,
- 10:50definitely in our primary care practices.
- 10:52And I always feel like it's then, you know, complicated also by,
- 10:56you know, some undercurrent of distrust or questioning.
- 10:59And so I have, you know, heart-to-heart conversations with patients a lot about this.
- 11:05And sometimes I'm negotiating, all right, you're due for these four or these
- 11:09five or whatever and you know I might say say if it's between Prebnar 20 and,
- 11:18Shingrix I might say well you know,
- 11:21shingles will probably won't kill you but just make you wish you were dead and
- 11:25the uh the the prevenars you know the likely or the pneumococcus is more likely
- 11:30to to invest invasive disease leading to death so,
- 11:34you know i might i might emphasize the one the single dose over the two as far
- 11:38as that that encounter but do you just,
- 11:41riffing off of that do you have any tricks for communication that that you have
- 11:47seen or heard or put into practice in your practice in your career?
- 11:52A few off the top of my head, kind of getting to what you were talking about,
- 11:55I usually like to educate patients about the disease you're being vaccinated against.
- 12:01And for different patients, the priority for different vaccines is going to
- 12:04be different. For example, someone with severe underlying COPD,
- 12:07I'm going to much more push for the pneumococcal, the RSV, the influenza vaccines
- 12:13than I am the Shingrix or hepatitis, right?
- 12:16For people with non-alcoholic fatty liver disease or cirrhosis,
- 12:19we're going to definitely be pushing for them to be immunized against hepatitis A and B, right?
- 12:24That's helpful. And when you describe to a patient kind of why they particularly
- 12:29would benefit the most from this vaccine, that can be very helpful.
- 12:33And I find a lot of people will come around to the idea of the vaccine that way.
- 12:37For example, I see a lot of people with chronic hepatitis C,
- 12:40and they're not always the most amenable to getting vaccines, I will say.
- 12:44But when I see them in the clinic and I explain that, you know,
- 12:46you had one hit to your liver and you may have some permanent damage to your
- 12:50liver as a part of the hepatitis C virus, it would behoove us to get you immunized
- 12:54hepatitis A and B, A of which you can get from going out to eat here in Maine, right?
- 12:59There's outbreaks all the time. And that can be very helpful.
- 13:02The other thing I do is I use a lot of opt-out language as opposed to opt-in language.
- 13:07That means saying things like, all right, we're going to do the hepatitis A
- 13:10vaccine today. Is that okay with you?
- 13:13You're still giving the person the option, of course, as every patient should be getting.
- 13:16But you're just changing the framing of the question a little bit so that studies
- 13:21show that people are more likely to accept a proposition if it's phrased as
- 13:26a opt-out way, as opposed to saying, do you want to get this vaccine today?
- 13:30Because face it, a lot of people don't necessarily want to get an injection.
- 13:34They don't want to get like a procedure. They don't want to feel a little bit unwell for a few days.
- 13:40So a lot of people say, yeah, no, even if they're not like very concerned about
- 13:45vaccines, they just often tend to put it off or say, you know,
- 13:50I'll do it another day or I'll think about it. That's good. That's great advice.
- 13:55When, as you see patients in consultation or, or involved in,
- 14:01in, you know, taking care of other providers, patients, do you,
- 14:06where do you see are some of the biggest opportunities where maybe we are,
- 14:09we're missing in primary care or that, that, that tend to be forgotten that
- 14:13may surprise you or you think we really need to be paying more attention?
- 14:18Good question. I would probably say it's identifying the people who need vaccination
- 14:24is probably the biggest thing we miss in primary care because,
- 14:28honestly, every vaccine has all these varied indications, and it is hard to
- 14:32know at any given time right off the bat what vaccines the person in front of
- 14:37you would be indicated for and benefit from, right?
- 14:40And our electronic medical records help a little bit with this,
- 14:43but they're still not perfect.
- 14:45So, it really helps If you need to print out a list and put it on your board,
- 14:52or put notes in your chart, if you pre-chart to try to self-select people,
- 15:00the easy ones are going to be influenza, right?
- 15:02Because everyone generally is recommended to get influenza, so that's an easy one.
- 15:06But like RSV, like we said, there's kind of those two tiers,
- 15:10everyone over the age of 75, but then 50 to 74 with a qualifying chronic condition.
- 15:16And people, I think, will see a patient, they'll think, oh, it's for 75 and
- 15:20older, you're not 75 and older, and then they just don't recommend it or don't
- 15:23discuss it when the person really could actually benefit from the vaccine.
- 15:28Other examples would be like pregnant patients, forgetting that they should
- 15:33be up to date on their tetanus shot or actually the tetanus diphtheria and pertussis
- 15:37shot, which I think a lot of people fall behind on because it's an every 10-year vaccine.
- 15:43Those are those are probably the hardest things i guess kind of tailoring off
- 15:47of this like what are some of the mistakes or or like,
- 15:51misconceptions i see among clinicians there's a few that i see quite repeatedly,
- 15:57one would be kind of that the concept that shared clinical decision making as
- 16:02is often phrased in the newer cdc vaccine schedules right,
- 16:07is almost like a code for we don't recommend this, right? And that's not the case.
- 16:12Shared decision-making really just means you present the patient with information
- 16:16about why they should potentially get the vaccine, and then you jointly come
- 16:20to a decision about getting the vaccine, right?
- 16:22Which is really what we should be doing with every vaccine and what we do do
- 16:26with every vaccine, right?
- 16:28I think sometimes when providers see that shared decision-making,
- 16:31they're like, I'll just kind of cross that one out. It's not critical, right?
- 16:34The second, I had touched on this earlier is the RSV shot is an annual shot.
- 16:38People will think it's not. It's a one and done.
- 16:41There is no recommendation for redosing.
- 16:44Another is egg allergies in people with flu vaccines. There are virtually no
- 16:49eggs being used in flu vaccines anymore. And actually in studies of people with
- 16:53egg allergies, the rate of having anaphylaxis to a flu shot is essentially zero.
- 16:58And so for a number of years now, it has been recommended to disregard egg allergy
- 17:02when giving out the flu shot of any kind.
- 17:05Probably the most common is the concern about giving multiple vaccines together,
- 17:10that they'll somehow be like a additive negative effect or an exponentially
- 17:15worse effect, or that they'll affect one another or that they can't be given together.
- 17:20That's actually not really the case with any vaccine. And actually,
- 17:23the data supports giving as many vaccines as possible in order to maximize people
- 17:28getting vaccines. If you split vaccines up, you're going to lose people,
- 17:32right? Not everyone's going to come to the follow-up appointment.
- 17:35That's historically the concern about splitting up, say, childhood vaccines.
- 17:39In theory, no one has an issue with spacing out vaccines as parents may prefer
- 17:46based on their perceptions of safety and risk.
- 17:49Of course, there's going to be a concern if you space things out too far and
- 17:52you put really important vaccines
- 17:54at the end, they could get the infection before they get to the vaccine.
- 17:58But the real concern there is if you split the vaccines up too many times,
- 18:02they're going to miss certain vaccines and fall through the cracks.
- 18:05And that's why it's really important whenever we can to give like combo vaccines,
- 18:09like the tetravalent meningococcal vaccines, the MMRV, so the combination varicella
- 18:16MMR vaccine, for example.
- 18:19I wonder too, if maybe now that we're kind of touching a little bit on pediatric
- 18:24vaccines, If we could just like,
- 18:27address sort of head on some of the confusion that's happening around vaccines, given the.
- 18:36Confusing messages that are sometimes coming out of Washington right now with
- 18:42regard to what the recommendations are around pediatric vaccines.
- 18:47If you could help kind of clarify things for us, that'd be great.
- 18:52Yeah, because it is incredibly complicated in the current, I'll say,
- 18:56political climate and what's going on at the federal level.
- 19:00Things are changing a mile a minute. And the biggest thing I would tell listeners
- 19:04is you really just have to stay up to date on the news because I can't even
- 19:10keep up, to be honest. Probably what has happened.
- 19:13Concerned providers the most is that there has been talk from Washington to
- 19:18dramatically upend the pediatric vaccine schedule, such as eliminating hepatitis A and B vaccination,
- 19:24meningococcus, rotavirus, RSV, influenza, COVID.
- 19:29They've changed some of those things, like the COVID recommendation language,
- 19:33before they were really able to update their vaccine schedules,
- 19:36there was a court order that stayed the prior immunization schedule.
- 19:42And so actually, as of right now, if you go to the CDC website and look at the
- 19:45vaccine schedules, it'll be the same vaccine schedules you saw several years ago.
- 19:50Granted, no one knows how long that court order will last, and if it is overturned,
- 19:55what exact changes will occur with the vaccine schedule.
- 19:58Will they no longer recommend any of those vaccines to pediatric patients?
- 20:03Will they just eliminate Some of them, from what we can tell,
- 20:07insurance coverage probably should not change significantly.
- 20:10So people who want vaccination should still be able to get it and get it covered.
- 20:14And in fact, something we should touch base briefly on, and now's a good time,
- 20:18would be the main immunization program has expanded its coverage to basically
- 20:23all adults under the, all people really, under the age of 65.
- 20:28So people with Medicare are not qualified, but everyone else can actually get
- 20:32a number of normal vaccines, cost-free, whether they have insurance,
- 20:39do not have insurance, or underinsured.
- 20:41And that should remain the case, that there's a state law, not a federal law,
- 20:44regardless of what the CDC changes its vaccine schedules to.
- 20:48That is so helpful, especially with that college-age kid who maybe didn't get
- 20:55their last vaccine at 18, and you're seeing them at 19.
- 21:01And then not to mention like all the adults who don't have great coverage or
- 21:04have huge deductibles. I was so excited to see the state do that.
- 21:10Yep. It's a huge boon.
- 21:13We've seen improved uptake in vaccines in our office already with implementing
- 21:18the program, and it was just such a no-brainer.
- 21:21And I'm very excited about that.
- 21:24Yeah, another benefit I thought about earlier was because you can offer these
- 21:29vaccines in the office, you actually increase uptake.
- 21:32And if you can get vaccines stocked in your office, which I think for most primary
- 21:37care clinics is a very sensible thing to do, patients are much more likely to
- 21:40get a vaccine in the doctor's office with that opt-out language than they are to go to a pharmacy.
- 21:45We see dramatic decreases in
- 21:47follow-through when patients have to go to a pharmacy to get the vaccine.
- 21:51Maybe the pharmacy doesn't have a person on duty that can give the vaccine at
- 21:55the time they go there, and then it just never happens.
- 21:58Right. It's any barriers we can remove it really makes a difference yeah definitely.
- 22:07I'm kind of curious what new and exciting stuff's coming down the road here.
- 22:14Yeah there so there's always new vaccines in development trying i think probably
- 22:19some of the most interesting ones here in maine that we're asked about,
- 22:23one would be the lyme vaccine so there is no actual lyme vaccine that's like up for FDA approval.
- 22:30That is going to be available in the very near future for patients to get at primary care clinics.
- 22:35But there has been research over the last decade into making a Lyme vaccine,
- 22:39including research that's being done right now in Maine Health.
- 22:42And it may be that in the next few years, we see FDA approval for one of these
- 22:46vaccines and it will become publicly available.
- 22:49So I think a lot of people in Maine would really appreciate that because of
- 22:51the enormous risk of Lyme disease.
- 22:54In Maine, it's important to note that that is just a Lyme vaccine,
- 22:56so it would not prevent other tick-borne infections, but it could potentially
- 23:00cut down on Lyme cases significantly in the state and across the country,
- 23:04really, because not just Maine, of course, that has Lyme disease.
- 23:07Other kind of exciting or novel vaccines that I would bring up,
- 23:12chikungunya vaccine has been available for the past several years.
- 23:15There were two versions originally. There was a live attenuated vaccine and
- 23:19then a virus-like particle or non-live vaccine.
- 23:23The live virus vaccine has been withdrawn because of risk of actual adverse events.
- 23:29And so now just the virus-like particle that cannot give people chikungunya,
- 23:34called the Vimkunya, is FDA-approved and licensed in the United States.
- 23:38That's not something most people are going to be getting, but it is recommended
- 23:41for people going to certain places in South America and Africa that are having.
- 23:46Active chikungunya outbreaks.
- 23:48Realistically, those are probably the most exciting things coming to vaccines
- 23:54or have come like in the last year or so.
- 23:57Do you know if the chikungunya vaccine would be available at most travel medicine clinics or?
- 24:04So, excellent question. Is that going to be a difficult thing to obtain?
- 24:07Yeah. So, I know at least in Maine Health, our travel clinics,
- 24:10and we have a travel clinic here in Brunswick, because of the cost of the chikungunya
- 24:14vaccine and the variable coverage from private payers mainly. and also Medicare,
- 24:20The reimbursement for in-office administrations is low or non-existent,
- 24:25and so we do not offer it in any of our clinics.
- 24:27Instead, patients are instructed to go to a pharmacy and get it there.
- 24:32It may be that like a for-profit travel clinic, I'm not positive,
- 24:36would have the vaccine ready, but most people, if they really want it,
- 24:40they can go to the pharmacy to get it.
- 24:43And I guess, is that just like a once in a lifetime thing? Or if people are,
- 24:48repeatedly traveling to areas that put them at risk, is it something that they
- 24:54would have to get repeatedly?
- 24:56Yeah, good question. It is, there's not really great studies on that because it's relatively new.
- 25:02It's currently just a single dose vaccine.
- 25:06I believe that they, trying to actually remember off the top of my head,
- 25:10if there was any studies that looked specifically at boosting.
- 25:13I believe not to see, but no, I don't believe so.
- 25:18Fortunately, I believe the studies actually showed a pretty enduring effect.
- 25:23No vaccine that is not live is going to truly cause lifelong immunity.
- 25:27Unfortunately, I believe the studies indicated that at least for several years,
- 25:33you would be pretty immune.
- 25:34If someone was repeatedly going, say, over a decade down to,
- 25:38say, Brazil and the Amazon during outbreaks of chikungunya.
- 25:43Although chikungunya is not considered a fatal disease, it can be a quite disabling disease.
- 25:47I think you could definitely consider repeat boosting. And it may be that in
- 25:52the next two years, as the vaccine gets more advanced, that there'll be a new
- 25:57recommendation to actually boost people.
- 25:59Yeah, that's great. And those are probably the people we'll be sending to you in the travel clinic.
- 26:09Yeah absolutely yes,
- 26:14that's great oh thank you so this has been so valuable and and i'm just thinking
- 26:19as we as we wind down the podcast any any last thoughts key takeaways that you would,
- 26:26want a primary care provider to be thinking about yeah,
- 26:32i would say the probably that's one of the key takeaways.
- 26:36One, the decision, the recommendation making that primary care providers are
- 26:41making about vaccines. Again, that opt-out language is really,
- 26:44really key and really coming across strong but not aggressive about vaccines.
- 26:52I would never force someone to get a vaccine, obviously. I don't think anyone
- 26:55would, but trying to be as pro-vaccine as possible.
- 26:59There are still a lot of people that really value what their doctor,
- 27:02especially their personal doctor, someone that they have had for a very long time says.
- 27:06And so really coming across confident and strong with those recommendations
- 27:10is going to significantly help with uptake.
- 27:13The next kind of takeaway would be the co-administering of vaccines.
- 27:16Again, there's really no evidence that multiple vaccines in a single day are going to harm people.
- 27:23And so, particularly for those routine vaccines, getting them all into the patient
- 27:27during that one clinic visit is just going to help patients complete their series
- 27:31and stay up to date better and be more protected.
- 27:34And then kind of other takeaways, the changes in the RSV coverage going down
- 27:39to the 50s, the pneumococcal vaccines going down to the 50s,
- 27:43the expanded flu shot availability,
- 27:46for the flu block, those sorts of things are definitely going to be really important
- 27:50to keep an eye on so that you're offering the vaccine to everyone that's potentially eligible.
- 27:56And then the last thing that's not really specific to just the past year,
- 28:00but always being very mindful of people with immunocompromise in particular,
- 28:04we're seeing more and more people with immunocompromising conditions.
- 28:08Nowadays, with the superfluous number of monoclonal antibodies for a variety
- 28:12of rheumatological and even oncological diseases, and although those are miracle
- 28:17drugs for the diseases they treat,
- 28:19they can definitely put people in a significant risk category where live vaccines
- 28:23in particular really should be avoided.
- 28:27That's great. Thank you so much. This was really informative and quite enjoyable. Thank you. Great.
- 28:36I was very happy to be here. Thank you so much for having me.
- 28:39Thanks for listening to Curbside Consult. To continue the conversation,
- 28:43please visit the MaineHealth ACO's LinkedIn page at LinkedIn forward slash company
- 28:49forward slash M-H-A-C-O.
- 28:53We welcome your reactions, thoughts, suggestions for what specialties to cover in the months to come.
- 28:59We also want to thank Jodi Urenic, Claire Houston, and Paul Santam.
- 29:04Menno for all of their help getting this podcast on the air. We'll see you next time.